1 Frequent Recovery of HIV-1 From Genital Herpes Simplex Virus Lesions in HIV-1–Infected Men

2 rancang bangun aplikasi antivirus komputer dengan menggunakan metode secure hash algorithm 1 (sha1) dan heuristic string

3 reação de inibição da hemaglutinação para o vírus da rubéola: técnica simplificada rubella hemagglutination-inhibition test: a simplified technique

4 In-field capable loop-mediated isothermal amplification detection of Turnip yellows virus in plants and its principal aphid vector Myzus persicae.

5 Immobilization of gold nanoparticles with rhodamine to enhance the fluorescence resonance energy transfer between quantum dots and rhodamine; new method for downstream sensing of infectious bursal disease virus

6 Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada.

7 Shared Molecular Signatures Across Neurodegenerative Diseases and Herpes Virus Infections Highlights Potential Mechanisms for Maladaptive Innate Immune Responses.

8 Reverse transcription recombinase polymerase amplification assay for rapid detection of canine associated rabies virus in Africa.

9 Delivery of antisense peptide nucleic acid by gold nanoparticles for the inhibition of virus replication.

10 Gold nanoparticles and hepatitis B virus

11 Yield parameters and antioxidant compounds of tomato fruit: the role of plant defence inducers with or without Cucumber mosaic virus infection.

12 Prognostic profile of patients with non-viral hepatocellular carcinoma: A comparative study with hepatitis C virus-related hepatocellular carcinoma using data mining analysis.

13 Genomic characterization of mumps viruses from a large-scale mumps outbreak in Arkansas, 2016.

14 Revealing uninfected and infected target cell dynamics from peripheral blood data in highly and less pathogenic simian/human immunodeficiency virus infected Rhesus macaque.

15 Activation of the autophagy pathway by Torovirus infection is irrelevant for virus replication.

16 Quantitative proteomics identify an association between extracellular matrix degradation and immunopathology of genotype VII Newcastle disease virus in the spleen in chickens.

17 Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies – a comprehensive review

18 Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population.

19 A model to study the inhibition of nsP2B-nsP3 protease of dengue virus with imidazole, oxazole, triazole thiadiazole, and thiazolidine based scaffolds.

20 Plasmonic Nanomaterial-Based Optical Biosensing Platforms for Virus Detection

21 Prediction and Staging of Hepatic Fibrosis in Children with Hepatitis C Virus: A Machine Learning Approach.

22 A high prevalence of human T-lymphotropic virus (HTLV 1/2) infection among Afro-descendants, Esmeraldas province, Ecuador – need for the implementation of surveys and control programs

23 Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies

24 Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]

25 Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

26 Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study

27 Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

28 Declining prevalence of hepatitis C virus among university students in one of the main governorates in Egypt

29 Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

30 Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia

31 Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant

32 Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents

33 Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

34 Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse

35 Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience

36 Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection

37 Right and left ventricular function in hospitalized children with respiratory syncytial virus infection

38 Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naïve hepatitis C genotype 1b-infected patients in western China

39 Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities

40 Drug resistance in influenza A virus: the epidemiology and management

41 Concern over Zika virus outbreak: another alarming global threat

42 Influence of host resistance on viral adaptation: hepatitis C virus as a case study

43 New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents

44 Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer

45 Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

46 Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

47 Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

48 Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

49 Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

50 Zika virus challenges for neuropsychiatry

51 A high prevalence of human T-lymphotropic virus (HTLV 1/2) infection among Afro-descendants, Esmeraldas province, Ecuador – need for the implementation of surveys and control programs

52 Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies

53 Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]

54 A high prevalence of human T-lymphotropic virus (HTLV 1/2) infection among Afro-descendants, Esmeraldas province, Ecuador – need for the implementation of surveys and control programs

55 Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies

56 Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]

57 Immunoinformatics Approach for Multiepitopes Vaccine Prediction against Glycoprotein B of Avian Infectious Laryngotracheitis Virus

58 Seroprevalence of Hepatitis B Virus and Associated Factors among Health Professionals in University of Gondar Hospital, Northwest Ethiopia

59 Molecular Characterization of African Swine Fever Viruses from Outbreaks in Peri-Urban Kampala, Uganda

60 Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase

61 Epstein-Barr Virus- (EBV-) Immortalized Lymphoblastoid Cell Lines (LCLs) Express High Level of CD23 but Low CD27 to Support Their Growth

62 A Rare Case of Herpes Simplex Virus-2 Hepatitis with Negative Serology

63 Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

64 Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study

65 Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

66 Declining prevalence of hepatitis C virus among university students in one of the main governorates in Egypt

67 Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

68 Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia

69 Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant

70 Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents

71 Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

72 Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse

73 Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience

74 Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection

75 Right and left ventricular function in hospitalized children with respiratory syncytial virus infection

76 Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naïve hepatitis C genotype 1b-infected patients in western China

77 Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities

78 Drug resistance in influenza A virus: the epidemiology and management

79 Concern over Zika virus outbreak: another alarming global threat

80 Influence of host resistance on viral adaptation: hepatitis C virus as a case study

81 New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents

82 Application of Optimal Control Theory to Newcastle Disease Dynamics in Village Chicken by Considering Wild Birds as Reservoir of Disease Virus

83 Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer

84 Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

85 Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

86 Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

87 Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

88 Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

89 Antibodies against Schmallenberg virus detected in cattle in the Otjozondjupa region, Namibia

90 Zika virus challenges for neuropsychiatry

91 Genotypic characterisation of Avian paramyxovirus type-1 viruses isolated from aquatic birds in Uganda

92 Genetic characterisation of African swine fever virus from 2017 outbreaks in Zambia: Identification of p72 genotype II variants in domestic pigs

93 Immunogenicity of a plasmid DNA vaccine encoding G1 epitope of bovine ephemeral fever virus G glycoprotein in mice

94 Peste des petits ruminants virus infection of Black Bengal goats showed altered haematological and serum biochemical profiles

95 Peste des petits ruminants in Africa: Meta-analysis of the virus isolation in molecular epidemiology studies

96 Development of a Colloidal Gold Kit for the Diagnosis of Severe Fever with Thrombocytopenia Syndrome Virus Infection

97 Illumina sequencing of clinical samples for virus detection in a public health laboratory

98 Combination therapy targeting platelet activation and virus replication protects mice against lethal influenza pneumonia.

99 Analytical performances of the BD Veritor™ System for the detection of respiratory syncytial virus and influenzaviruses A and B when used at bedside in the pediatric emergency department.

100 Development of a reverse transcription recombinase polymerase amplification assay for rapid detection of human respiratory syncytial virus.

101 Report on Influenza A and B Viruses: Their Coinfection in a Saudi Leukemia Patient

Keyword Connections

Journals

Research Groups

Bibliographies